{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001717","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2025-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.793754+00:00","generated_at":"2026-05-17T05:39:16.372803+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lexaria Bioscience terminates $5M equity distribution agreement with JonesTrading","bullets":["Terminated Capital on Demand Sales Agreement with JonesTrading effective September 19, 2025.","Agreement allowed up to $5M in common stock; only 14,995 shares sold for $38,236 gross proceeds.","Original agreement dated Aug 21, 2024; amended Feb 5, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001717","json":"https://secwatch.observer/filing/0001640334-25-001717.json","markdown":"https://secwatch.observer/filing/0001640334-25-001717.md","text":"https://secwatch.observer/filing/0001640334-25-001717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033425001717/0001640334-25-001717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033425001717/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:39:16.372803+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}